Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Danny Hsu: Fascinating Insight into the Cellular Mechanisms of Statins in APLS
Danny Hsu/LinkedIn
Dec 13, 2025, 08:49

Danny Hsu: Fascinating Insight into the Cellular Mechanisms of Statins in APLS

Danny Hsu, President of THANZ, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:

”Fascinating insight into the cellular mechanisms of statins in APLS.”

Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:

”Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies

By Dominika Marova, Paul Frankenbach, Dr. Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl Lackner, and Nadine Müller Calleja

Antiphospholipid antibodies (aPLs) drive thrombosis and inflammation via endothelial protein C-receptor (EPCR)–mediated binding of lysobisphosphatidic acid (LBPA).

Statins may exert direct anti-APS effects through molecular competition at EPCR–lipid interfaces, not merely via lipid-lowering or pleiotropic vascular actions.”

Read the full article here.

Article: Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies

Authors: Dominika Marova, Paul Frankenbach, Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl J. Lackner, Nadine Müller-Calleja

Danny Hsu

Stay updated on all scientific advances with Hemostasis Today.

Anne Hollerbach Antiphospholipid Antibodies APLS Danny Hsu Dominika Marova Endothelial Protein C-Receptor EPCR Hematology Hemostasis Today Journal of Thrombosis and Haemostasis JTH Karl J. Lackner Nadine Müller-Calleja Paul Frankenbach Susanne Strand thrombosis Wolfram Ruf
NewsFeed